Myeloid-derived suppressor cells (MDSC) impair T cell function in tumor-bearing hosts through one or more processes, including the depletion of the amino acids arginine and cysteine, the release of reactive oxygen species and nitric oxide, and the induction of regulatory T cells. However, the molecular mechanisms by which T cells become dysfunctional after contact with MDSC remain unclear. Notch homolog 1-translocation-related protein (Notch-1) has been determined to be an important signal transduction molecule in the promotion of acute lymphoblastic T cell leukemia. However, its influence on normal T cell responses is poorly understood. The proposed study will be the first to determine the significance of the inhibition of Notch-1 in T lymphocytes in the MDSC-induced T cell suppression occurring in solid tumors. Further, through the use of novel antigen- specific transgenic murine models, this investigation will advance the understanding of the role of Notch-1 in normal T cell proliferation, cytotoxicity, and cytokine production. In preliminary studies, tumor-infiltrating MDSC expressing arginase I inhibited the expression of Notch-1 in activated T cells at the same ratios at which they blocked T cell proliferation. In addition, activated T cells cultured with inhibitors of Notch-1 cleavage displayed decreased cell proliferation and impaired production of interferon gamma (IFN?). These results were confirmed in cells from Notch-1 conditional knockout mice, in which proliferation of activated T cells also decreased. The preliminary data suggest that Notch-1 plays a significant role in normal T cell function and that a decrease in T cell-Notch-1 expression is a possible mechanism for the MDSC-induced T cell inhibition in tumors. Thus, we hypothesize that MDSC induced in solid tumors inhibit the expression of Notch-1 in T cells and thereby impair the development of a protective anti-tumor T cell response. The completion of this research is expected to provide mechanistic insights into the suppression of T cells by MDSC in cancer. This study may also enable the design of new therapeutic approaches to reverse T cell tolerance in cancer or other conditions such as autoimmune diseases, chronic infections, and trauma, which are characterized by the accumulation of MDSC. To test our hypothesis and to achieve the objectives of this project, we propose the following Specific Aims:
Specific Aim 1 : Test the prediction that arginase I-expressing MDSC inhibit T cell function in vitro by impairing the expression of Notch-1.
Specific Aim 2 : Determine in vivo the role of Notch-1 in the T cell suppression induced by tumor-infiltrating MDSC.
This study will determine the role of Notch homolog 1-translocation-related protein (Notch-1) in the T cell suppression induced by myeloid-derived suppressor cells (MDSC) in tumors. Information garnered from this effort is expected to provide insights into the mechanisms underlying T cell suppression in cancer, which may enable the design of new therapeutic approaches to prevent and/or reverse T cell tolerance in tumors. These approaches may also benefit patients suffering from other conditions such as autoimmunity diseases, chronic infections, and trauma, which are also characterized by the accumulation of MDSC.
|Fletcher, Matthew; Ramirez, Maria E; Sierra, Rosa A et al. (2015) l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells. Cancer Res 75:275-83|
|Raber, Patrick L; Thevenot, Paul; Sierra, Rosa et al. (2014) Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. Int J Cancer 134:2853-64|
|Thevenot, Paul T; Sierra, Rosa A; Raber, Patrick L et al. (2014) The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors. Immunity 41:389-401|
|Sierra, Rosa A; Thevenot, Paul; Raber, Patrick L et al. (2014) Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer. Cancer Immunol Res 2:800-11|
|Morrow, K; Hernandez, C P; Raber, P et al. (2013) Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia. Leukemia 27:569-77|
|Hernandez, Claudia P; Morrow, Kevin; Velasco, Cruz et al. (2013) Effects of cigarette smoke extract on primary activated T cells. Cell Immunol 282:38-43|
|Guo, Gang; Marrero, Luis; Rodriguez, Paulo et al. (2013) Trp53 inactivation in the tumor microenvironment promotes tumor progression by expanding the immunosuppressive lymphoid-like stromal network. Cancer Res 73:1668-75|
|Naura, Amarjit S; Kim, Hogyoung; Ju, Jihang et al. (2013) Minocycline blocks asthma-associated inflammation in part by interfering with the T cell receptor-nuclear factor ýýB-GATA-3-IL-4 axis without a prominent effect on poly(ADP-ribose) polymerase. J Biol Chem 288:1458-68|
|Hill, James M; Stern, Ethan M; Bhattacharjee, Partha S et al. (2013) The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model. Antiviral Res 100:14-9|